Overview
Lobbying Costs
50,000€ - 99,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
0.8 Fte (8)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
The Health Policy Partnership (HPP)
EU Transparency Register
223430420230-66 First registered on 08 Jan 2016
Goals / Remit
We are a specialist health policy consultancy. We create innovative policy initiatives and powerful evidence–based communications for organisations across the health spectrum. We provide a unique, seamless approach to help resolve the most complex issues facing our health care systems. We do this through rigorous research and expert synthesis of evidence, inter-sectoral collaboration, and powerful communications that act as the starting point for meaningful changes in policy and practice.
Main EU files targeted
Public health and healthcare policy, specific focus in cancer, heart failure, and respiratory issues.
Website
-
People
Total lobbyists declared
8
Employment time Lobbyists 10% 8 Lobbyists (Full time equivalent)
0.8
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
Time provided above relates to HPP staff time dedicated to any formal engagement with MEPs, EU officials, or where there is policy activity directly involving or targeting EU institutions - i.e. it excludes general health policy activities where other audiences are our primary targets (e.g. national policy makers, academic experts, clinicians, health providers etc), and global activities.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Professional consultancies
-
Networking
Affiliation
Heart Failure Policy Network - www.hfpolicynetwork.eu
(provide secretariat and lead project)Member organisations
Please see www.hfpolicynetwork.eu
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
50,000€ - 99,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
50,000€ - 99,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
HEART FAILURE POLICY NETWORK (HFPN) HPP acts as Secretariat for HFPN, a multidisciplinary group of experts from across Europe working with patients, health professionals and other stakeholders to lead significant policy changes that may improve the lives of people with heart failure (HF). In April 2024, the HFPN organised an international online summit on HF, which featured Demetris Papadakis MEP as a speaker. The HFPN has ongoing relationships with several MEPs who donate their time for free to support (and act as Members of) the HFPN. In 2023, HFPN initiated the European Heart Failure Mission which aimed to secure political recognition and investment for HF from the EU. As part of the Mission, HFPN published a submission to the Hungarian Presidency of the EU calling for inclusion of heart failure in conclusions on cardiovascular health. The submission was launched at a dedicated policy event in Budapest in October 2024. It has been sent directly to selected MEPs and widely shared online in order to secure adequate prioritisation of heart failure in EU policy. HFPN has also been in contact with Oliver Varhelyi, Commissioner for health and animal welfare. The EU Mission activities are funded by AstraZeneca and Roche Diagnostics.
ACCELERATING ACTION: LESSONS FROM LUNG CANCER SCREENING IN CENTRAL AND EASTERN EUROPE In May 2024, The Lung Cancer Policy Network organised an in-person roundtable event in Warsaw, Poland. The event was attended by patient advocates, clinicians and researchers to discuss priorities and lessons from existing lung cancer screening activity in Central and Eastern Europe. Penilla Gunther from the European Cancer Organisation spoke in her role as part of the EU Cancer Mission Board.
DETECTING LUNG CANCER EARLIER: THE NEED FOR EFFECTIVE NATIONAL STRATEGIES. In November 2024, the Lung Cancer Policy Network hosted an online webinar focused on the importance of earlier detection for lung cancer, highlighting the different approaches being taken to achieve this around the world. An MEP virtually attended this event and viewed the proceedings.
- Adriana Jelovcic (Accredited Parliamentary Assistant at the European Parliament) attended as a viewerOther activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 25 Oct 2023 Location Brussels, Belgium Subject Role of the EU in promoting heart health Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Katherine Power (Cabinet member)